This article is more than 5 years old. Information may no longer be current.

FDA approves generic version of Lyrica

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA recently granted Lupin Pharmaceuticals final approval to produce the anticonvulsant drug pregabalin, which is used to treat fibromyalgia, epilepsy, post-herpectic neuralgia and diabetic peripheral neuropathy.

Pregabalin is the generic version of Lyrica (Pfizer).

The FDA approved Lupin to produce 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg capsules, although the company has not announced a production date.